Fabian V. Filipp

3

Articles

2

Comments
Professor Fabian V. Filipp lectures on the biology of malignant melanoma and pigmentation disease. The color of skin is due to the presence of a pigment called melanin, which can absorb cancer-causing sunlight. Photo by Systems Biology and Cancer Metabolism Laboratory, Fabian V. Filipp. Used with permission. CC BY-SA.

Success of immunotherapy stimulates future pigment cell and melanoma research

Fabian V. Filipp, University of California, Merced

An international team of researchers is probing the links between skin diseases, including cancer, to speed the search for cures.
Professor Fabian V. Filipp with his team working on precision targeting of malignant melanoma. Systems Biology and Cancer Metabolism Laboratory

Sure, cancer mutates, but it has other ways to resist treatment

Fabian V. Filipp, University of California, Merced

Cancer is a disease of our genes, but resistance to therapy might go beyond cancer mutations. The DNA stays the same, but cancer cells outsmart the drugs by switching their gene activity.
Cancer precision targeting at the Systems Biology and Cancer Metabolism Laboratory. Credit: Systems Biology and Cancer Metabolism Laboratory. Fabian V. Filipp

Can the study of epigenomics lead to personalized cancer treatment?

Fabian V. Filipp, University of California, Merced

A field called epigenomics looks at chemical modifications that do not change our DNA sequence but can affect gene activity. What are the limitations, and can biomedicine use this to our advantage?

Contact Fabian for

  • Media request
  • Speaking request
  • Consulting / Advising
  • Research collaboration
  • Location: CA, USA
  • Website
  • Article Feed
  • ORCID
  • Joined